BlackRock Health Sciences Trust Overview
Pro stress-test →BlackRock Health Sciences Trust is a closed-end management investment company with an investment objective to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust invests at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Strategic Profile
Pro stress-test →The Trust pursues its goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options. Led by portfolio manager Erin Xie, PhD, Managing Director and head of the Health Sciences team at BlackRock, with over two decades of experience including prior management of the State Street Health Sciences Fund.
Competitive Landscape
Pro stress-test →Primary competitors in the closed-end healthcare fund space include other BlackRock health-focused trusts and healthcare-focused closed-end funds from competitors like Invesco, Nuveen, and Gladstone Capital. BME differentiates through BlackRock's institutional expertise, options strategy overlay, and healthcare sector specialization.
Industry Context
BlackRock Health Sciences Trust operates in Closed-End Investment Funds / Healthcare Equities.
Key facts
Founded: 2005 · Headquarters: New York, US · Market cap: $500M